ICD10 code of Duchenne muscular dystrophy and ICD9 code

The International Classification of Diseases (ICD) codes for Duchenne muscular dystrophy are G71.01 in the ICD-10-CM system and 359.1 in the ICD-9-CM system. These codes are utilized by healthcare providers and insurance companies to standardize documentation and billing for patients living with this progressive neuromuscular condition.

What is the clinical significance of these coding systems for Duchenne muscular dystrophy?

Duchenne muscular dystrophy is a severe, X-linked recessive disorder characterized by the progressive degeneration of muscle tissue. The use of the specific ICD-10 code G71.01 is essential for medical record accuracy, as it distinguishes Duchenne muscular dystrophy from other forms of muscular dystrophy, such as Becker muscular dystrophy. Accurate coding ensures that the specific clinical requirements of individuals with Duchenne muscular dystrophy are recognized by medical systems, facilitating access to specialized multidisciplinary care, physical therapy, and emerging gene-based therapies.

How is Duchenne muscular dystrophy diagnosed and tracked?

Diagnosis of Duchenne muscular dystrophy typically involves a combination of clinical evaluation, genetic testing to identify mutations in the dystrophin gene (DMD), and biochemical testing, such as elevated creatine kinase (CK) levels. Because Duchenne muscular dystrophy affects approximately 1 in every 3,500 to 5,000 live male births globally, early identification through these standardized codes is critical for initiating early intervention strategies. Within the DiseaseMaps.org community, 38 people with Duchenne muscular dystrophy have shared their experiences, highlighting the value of connecting with others who navigate the same complex healthcare landscape.

What should families know about the inheritance of Duchenne muscular dystrophy?

Duchenne muscular dystrophy is caused by mutations in the dystrophin gene located on the X chromosome. Because of this inheritance pattern, the condition primarily affects males, while females are typically carriers who may or may not exhibit mild symptoms. When a family receives a diagnosis of Duchenne muscular dystrophy, genetic counseling is strongly recommended to:

• Understand the 66% inheritance rate from carrier mothers versus the 33% rate of *de novo* (spontaneous) mutations.


• Assess the risk of recurrence in future pregnancies.


• Provide carrier testing for female relatives who may be at risk of passing the mutation to their children.


• Discuss family planning options, including preimplantation genetic diagnosis (PGD).

Next steps

• Consult a Neuromuscular Specialist: Ensure your care is managed by a multidisciplinary team, including a pediatric neurologist, cardiologist, and pulmonologist.


• Verify Insurance Coverage: Confirm that your healthcare providers are using the correct ICD-10 code (G71.01) to support claims for specialized treatments and equipment.


• Join a Support Community: Connect with the 38 members on DiseaseMaps.org to share resources, clinical trial information, and emotional support.


• Stay Informed: Regularly check resources like the Parent Project Muscular Dystrophy (PPMD) for updates on the latest clinical research and standard-of-care guidelines.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Duchenne muscular dystrophy (ORPHA576).


• NIH GARD: Genetic and Rare Diseases Information Center - Duchenne muscular dystrophy.


• OMIM: Muscular Dystrophy, Duchenne Type (MIM #310200).


• Parent Project Muscular Dystrophy (PPMD): Clinical care standards for Duchenne muscular dystrophy.